Literature DB >> 14650449

Clinical use of methadone.

Cherokee Layson-Wolf1, Jean-Venable Goode, Ralph E Small.   

Abstract

Methadone hydrochloride is a mu-opioid agonist that has been used for the treatment of pain and for the management and maintenance of opioid withdrawal for over 50 years. Several characteristics make methadone a useful drug. However, these same characteristics and wide interpatient variability can make methadone difficult to use safely. A MEDLINE search was conducted on publications between January 1996 and May 2001 to identify literature relevant to this subject. Those publications were reviewed, and from them, other literature was identified and reviewed. Published studies demonstrate methadone's efficacy in pain management and in opioid withdrawal. However, interpatient variability in pharmacokinetic variables of methadone produces difficulties in developing guidelines for methadone use. Clinicians should not be deterred from use of this drug which has been shown to benefit patients in both pain management and methadone maintenance, but an individualized patient approach must be taken to use methadone safely.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 14650449

Source DB:  PubMed          Journal:  J Pain Palliat Care Pharmacother        ISSN: 1536-0288


  8 in total

1.  Characterization of the antinociceptive effects of the individual isomers of methadone after acute and chronic administrations.

Authors:  Richard W Morgan; Katherine L Nicholson
Journal:  Behav Pharmacol       Date:  2011-09       Impact factor: 2.293

2.  Successful prophylactic treatment of chronic cluster headache with low-dose levomethadone.

Authors:  T Sprenger; C L Seifert; M Miederer; M Valet; T R Tölle
Journal:  J Neurol       Date:  2008-08-04       Impact factor: 4.849

3.  Buprenorphine and methadone in the treatment of opioid dependence: methods and design of the COBRA study.

Authors:  Hans-Ulrich Wittchen; Sabine M Apelt; Gerhard Bühringer; Markus Gastpar; Markus Backmund; Jörg Gölz; Michael R Kraus; Felix Tretter; Jens Klotsche; Jens Siegert; David Pittrow; Michael Soyka
Journal:  Int J Methods Psychiatr Res       Date:  2005       Impact factor: 4.035

4.  Blockade of morphine-induced behavioral sensitization by a combination of amisulpride and RB101, comparison with classical opioid maintenance treatments.

Authors:  L Cordonnier; M Sanchez; B P Roques; F Noble
Journal:  Br J Pharmacol       Date:  2007-03-12       Impact factor: 8.739

5.  Continuing methadone for pain in palliative care.

Authors:  Philippa Hawley; Ryan Liebscher; Jessica Wilford
Journal:  Pain Res Manag       Date:  2013 Mar-Apr       Impact factor: 3.037

6.  Prevalence and longitudinal correlates of recent exposure to fentanyl among HIV-positive people who use unregulated drugs during a community-wide overdose crisis.

Authors:  Soroush Moallef; Ekaterina Nosova; Seonaid Nolan; Nadia Fairbairn; Jane Loh; Kanna Hayashi; M-J Milloy
Journal:  AIDS Care       Date:  2021-03-25

7.  Prevalence of pulmonary edema among the deceased cases with acute Methadone poisoning: A report from Iran.

Authors:  Nastaran Eizadi-Mood; Seyed Amir Hossein Madani Naeini; Mahrang Hedaiaty; Ali Mohammad Sabzghabaee; Maryam Moudi
Journal:  J Res Pharm Pract       Date:  2016 Oct-Dec

8.  Patient perspectives of methadone formulation change in British Columbia, Canada: outcomes of a provincial survey.

Authors:  Alissa M Greer; Sherry Hu; Ashraf Amlani; Sarah Moreheart; Olivia Sampson; Jane A Buxton
Journal:  Subst Abuse Treat Prev Policy       Date:  2016-01-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.